CVSA vs LOPE
CVSA: Covista Inc. is a leading US healthcare education provider offering degree and certificate programs across nursing, medicine, and veterinary fields to address critical workforce shortages. LOPE: Grand Canyon Education is a specialized service provider that powers online and campus-based education by delivering essential technology, counseling, and marketing support to universities.
Side-by-side fundamentals
| Metric | CVSA | LOPE | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $130.29 | $160.30 | |
| Market cap | $4.4B | $4.2B | |
| P/E as of 2026-10-08 | 20.31 | 19.36 | LOPE lower |
| PEG as of 2026-10-08, 3-year EPS CAGR to FY2025 | n/a | 1.86 | |
| Net margin | +12.9% | +19.5% | LOPE higher |
| Operating margin | +19.6% | +24.0% | LOPE higher |
| ROE | +17.4% | +28.9% | LOPE higher |
| ROA | +8.4% | +21.8% | LOPE higher |
| Debt / equity as of 2026-09-03 | 0.37 | 0.00 | LOPE lower |
| Revenue growth (YoY) as of 2026-09-03 | +9.7% | +7.0% | CVSA higher |
| Revenue CAGR (3y) SEC XBRL | +10.4% | +6.7% | CVSA higher |
| Dividend streak (yrs) SEC XBRL | 0 | 0 | Tie |
| Beta as of 2026-09-03 | 0.68 | 0.54 | |
| 1-year return as of 2026-10-08 close | -11.0% | -24.0% | CVSA higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.